Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Life Sciences
Retinoic Acid Hydroxylase Inhibitors As A Novel Therapy For Alzheimer’S Disease, Isabel M. Makman
Retinoic Acid Hydroxylase Inhibitors As A Novel Therapy For Alzheimer’S Disease, Isabel M. Makman
Undergraduate Theses, Professional Papers, and Capstone Artifacts
Alzheimer’s Disease (AD) is one of the most prevalent neurodegenerative diseases afflicting the modern world. As no cure for AD has yet been discovered we sought to explore a potential treatment option based on the inhibition of retinoic acid (RA) metabolism, the active metabolite of vitamin A. Beta-amyloid plaques form in the brain and decrease cognitive function in AD patients. In a recent preclinical study RA was shown to decrease these plaques and rescue memory deficits in an Alzheimer’s mouse model[i]. One key limitation is that when RA is administered to humans it induces its own breakdown, making …